Adoptive Cell Therapy in Hepatocellular Carcinoma: Biological Rationale and First Results in Early Phase Clinical Trials

Adoptive Cell Therapy in Hepatocellular Carcinoma: Biological Rationale and First Results in Early Phase Clinical Trials

The mortality of hepatocellular carcinoma (HCC) is quickly increasing worldwide. In unresectable HCC, the cornerstone of systemic treatments is switching from tyrosine kinase inhibitors to immune checkpoints inhibitors (ICI). Next to ICI, adoptive cell transfer represents another promising field of...

Full description

Bibliographic Details
Main Authors: Philippe Rochigneux, Brice Chanez, Bernadette De Rauglaudre, Emmanuel Mitry, Christian Chabannon, Marine Gilabert
Format: Article
Language:English
Published: MDPI AG 2021-01-01
Series:Cancers
Subjects:
hepatocellular carcinoma
immunotherapy
adoptive cell transfer
CAR-T cells
engineered TCR
Online Access:https://www.mdpi.com/2072-6694/13/2/271

Internet

https://www.mdpi.com/2072-6694/13/2/271

Similar Items